HORIZON PHARMA, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 22, 2013 5.00% Convertible Senior Notes due 2018Horizon Pharma • November 25th, 2013 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York
INDENTURE dated as of November 22, 2013 between HORIZON PHARMA, INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
HORIZON PHARMA, INC. and HORIZON PHARMA USA, INC. 8.750% SENIOR NOTES DUE 2024 INDENTURE Dated as of October 25, 2016 U.S. BANK NATIONAL ASSOCIATION, as TrusteeHorizon Pharma • October 25th, 2016 • Horizon Pharma PLC • Pharmaceutical preparations • New York
INDENTURE dated as of October 25 2016 among HORIZON PHARMA, INC., a Delaware corporation, HORIZON PHARMA USA, INC., a Delaware corporation, the Guarantors from time to time party hereto and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”).
